Nature of Business and Basis of Presentation - Schedule of Restatement Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2022	Mar. 31, 2021
Condensed Financial Statements, Captions [Line Items]
Research and development	$ 27,281	$ 17,411
General and administrative	9,755	3,898
Total operating expenses	37,036	$ 21,309
As Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Research and development	8,012
General and administrative	29,024
Total operating expenses	37,036
Adjustment [Member]
Condensed Financial Statements, Captions [Line Items]
Research and development	19,269
General and administrative	$ (19,269)

The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Name:	us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration